Insider Transactions Reported by 26 Insiders of GYRE THERAPEUTICS, INC.

Symbol
GYRE on Nasdaq
Location
San Diego, CA

Insiders trading volume in the past year

GYRE THERAPEUTICS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
GNI Group Ltd. 10%+ Owner $31,096,555 30 Oct 2023
Songjiang Ma President, Director $28,257,265 -$321,487 -1.1% 27 May 2025
Ying Luo Director $1,334,977 14 Aug 2024
Weiguo Ye Chief Operating Officer $525,000 01 Apr 2025
Thomas Wilson Eastling Director $103,950 04 Jun 2025
NASSIM USMAN Director $27,321 28 Jun 2024
Eddie Williams Director $16,358 07 Jan 2022
Geoffrey Ling MD Director $14,941 07 Jan 2022
ERROL B. DESOUZA Director $14,006 01 Oct 2021
Howard Levy Chief Medical Officer $11,293 09 Aug 2021
Grant E. Blouse Chief Scientific Officer $4,426 09 Aug 2022
AUGUSTINE LAWLOR Director 31 Aug 2023
JEANNE Y. JEW Director 09 Sep 2021
Andrea Hunt Director 31 Aug 2023
Seline E. Miller SVP Finance; Interim CFO & PAO 31 Aug 2023
SHARON TETLOW Director 09 Jun 2021
GNI Hong Kong Ltd 10%+ Owner 27 Oct 2023
David M. Epstein Director 04 Jun 2025
Gordon Carmichael Director 04 Jun 2025
Charles C. Wu Chief Executive Officer, Director 20 Nov 2023
Dan Weng Director 18 Aug 2025
Han Ying Chief Executive Officer, Director 14 Aug 2024
Ruoyu Chen Chief Financial Officer 07 Jan 2026
Renate Parry Director 04 Jun 2025
Rodney L. Nussbaum Director 04 Jun 2025
Ping Zhang Director 07 Jan 2026

Recent Insider Transactions by Companies or Individuals for GYRE THERAPEUTICS, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.